ELLIPSE VR, Tiered-therapy cardioverter/defibrillator, REF: CD1411-36Q, UDI: 05414734507738
FDA Device Recall #Z-2072-2019 — Class I — June 20, 2019
Recall Summary
| Recall Number | Z-2072-2019 |
| Classification | Class I — Serious risk |
| Date Initiated | June 20, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | St Jude Medical Inc. |
| Location | Sylmar, CA |
| Product Type | Devices |
| Quantity | 52 |
Product Description
ELLIPSE VR, Tiered-therapy cardioverter/defibrillator, REF: CD1411-36Q, UDI: 05414734507738
Reason for Recall
Electrical failures were identified in cardioverter defibrillators (ICDs) due to damaged aluminum wires. ICDs may contain electrical wire connections which may not be completely insulated. The potential patient impact could be the inability to deliver high voltage therapy. There is no available option to verify the vulnerability status for implanted devices.
Distribution Pattern
Worldwide distribution. US nationwide, and countries: DE, FR, IT, ES, NL, PT, SE, HU, DK, PL, IL, GP, DZ, CH, SA, SK, LU, NZ, VN, and NO
Lot / Code Information
Serial Number: 9828978, 9829577, 9830723, 9830869, 9831468, 9831616, 9831748, 9831795, 9831810, 9831919, 9833545, 9833546, 9834026, 9834051, 9834053, 9834055, 9834059, 9834063, 9834071, 9834140, 9834145, 9834167, 9834171, 9834256, 9834258, 9834259, 9834262, 9834265, 9834271, 9834272, 9834274, 9834275, 9834277, 9834285, 9834289, 9834291, 9834296, 9834299, 9834301, 9834302, 9834329, 9834398, 9834403, 9834407, 9834409, 9834418, 9834422, 9834423, 9834428, 9834431, 9834432, 9834553
Other Recalls from St Jude Medical Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2070-2019 | Class I | ELLIPSE VR, REF: CD1377-36C Implantable card... | Jun 20, 2019 |
| Z-2071-2019 | Class I | ELLIPSE VR, REF: CD1377-36QC Implantable car... | Jun 20, 2019 |
| Z-2075-2019 | Class I | ELLIPSE DR, Tiered-therapy cardioverter/defibri... | Jun 20, 2019 |
| Z-2073-2019 | Class I | ELLIPSE DR, REF: CD2377-36QC Implantable car... | Jun 20, 2019 |
| Z-2074-2019 | Class I | ELLIPSE DR, Tiered-therapy cardioverter/defibri... | Jun 20, 2019 |
Frequently Asked Questions
Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.